Empro Group Inc (EMPG) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Public company logo of Empro (EMPG)

The business resilience of Empro Group Inc (EMPG) is based on strict sanitary production controls and deep, clinically proven brand trust. The Malaysian manufacturer is successfully capturing the Asian cosmetics market, expanding its presence through aesthetic and medical product lines. The price action based on the EV/EBITDA multiple, which currently stands at , underscores the defensive qualities of the asset, which remains independent of global economic fluctuations.

Empro - EMPG Total Company Value to Operating Income Before Depreciation Ratio (period 07/04/2022 - 11/10/2026)

EMPG (empro.my): analytical breakdowns and indicator data

- market price and analyst price targets:
Price Chart Empro|EMPG - Analyst Median Target
- market capitalization details:
Market Value Empro Corporation|EMPG - Enterprise Value
- book value of equity indicators:
Book Value per Share Empro Group|EMPG - Book Valuation of Business|Market Value to Book Value Ratio empro.my|EMPG - Total Business Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Empro Group Inc|EMPG - Long-Term Liabilities to Capital|Short-Term Debt to Equity Empro Group|EMPG - Company Total Debt|Debt to Book Capitalization Ratio Empro Corporation|EMPG - Long-Term Liabilities|Company Short-Term Debt Empro Group|Quick Liquidity empro.my
- financial results and valuation multiples details:
EMPG - Company Net Income|Future Profit Empro Group Inc|EMPG - Company Value to Net Income|Forward P/E Multiple Empro Group Inc|EMPG - Price to Net Income Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Empro Corporation|EMPG - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Empro Group|EMPG - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months empro.my|EMPG - Earnings growth in current year|Net earnings per share growth forecast for next year Empro Group Inc
Analysis of all company metrics:EMPG (Empro)
Product sample of Empro Group

To assess the stability of Empro Group Inc (EMPG), the EV/EBITDA multiple is utilized, which compares the total enterprise value, including debt and taxes, against its operating profit. The current EV/EBITDA value of helps determine the degree of asset undervaluation amid the expansion of bio-cosmetics in Asia and the growth of high-margin e-commerce, confirming the effectiveness of the business model's scaling.

Direct competitors

Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Krystal Corp KRYS|Total Company Value to Operating Income Before Depreciation Ratio Apogee Corp (APGE)|ARQT - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|VCEL - EV/EBITDA Multiple|ORKA: EV/EBITDA Multiple|SMTI - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization DBV Tech|Enterprise Value to Operating Income Before Depreciation SLSN (Solesence Inc.)|EV/EBITDA Multiple DERM|FBRX - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sol-Gel Technologies Ltd. SLGL|AXIL - Enterprise Value to EBITDA Ratio|MDCX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio VRCA|hoththerapeutics.com (HOTH) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Biofrontera - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization VYNE Therapeutics, Inc.|Company Value to EBITDA Sonoma Pharma SNOA|Enterprise Value to EBITDA Ratio QNRX (Quoin Pharmaceuticals)|AZTR (Azitra Corporation) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple DRMA (Dermata Therapeutics)|Enterprise Value to EBITDA Multiple elevaiskincare.com|RVNC - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization